Diabetes Devices Market To Touch US$66,053.1 mn By 2025
Diabetes mellitus, often referred as diabetes, is a chronic condition that results when there are elevated levels of glucose in the blood. High blood glucose levels occur when our body is unable to produce any or enough of the hormone insulin or use it effectively. Insulin is produced in the pancreas and is an essential hormone for transporting glucose from our blood stream into the body cells where it gets converted into energy. The lack of insulin or the inability of the cells to respond to insulin leads to high levels of blood glucose, or hyperglycemia, which causes diabetes.
Diabetes mellitus, often referred as diabetes, is a chronic condition that results when there are elevated levels of glucose in the blood. High blood glucose levels occur when our body is unable to produce any or enough of the hormone insulin or use it effectively. Insulin is produced in the pancreas and is an essential hormone for transporting glucose from our blood stream into the body cells where it gets converted into energy. The lack of insulin or the inability of the cells to respond to insulin leads to high levels of blood glucose, or hyperglycemia, which causes diabetes.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Global <strong>Diabetes</strong> <strong>Devices</strong> and Drugs <strong>Market</strong>: Segmental Highlights and Table of Content (2013 -<br />
2019)<br />
Global <strong>Diabetes</strong> <strong>Devices</strong> and Drugs <strong>Market</strong>: SGLT-2 Inhibitors Segment to Expand at<br />
Impressive 76.80% CAGR from 2013 to 2019<br />
The global diabetes devices and drugs market will expand at a moderate CAGR of 5.90% during the<br />
forecast period from 2013 to 2019, according to a report from Transparency <strong>Market</strong> Research<br />
(TMR). This report is titled “<strong>Diabetes</strong> <strong>Devices</strong> and Drugs <strong>Market</strong> - Global Industry Analysis,<br />
Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019”. In 2012, the global<br />
diabetes devices and drugs market was worth more than US$54.0 bn and by 2019, the market is<br />
projected to be worth US$83.0 bn.<br />
Therapy-wise, the global diabetes devices and drugs market is segmented into insulin, non-insulin<br />
injectable anti-diabetes drugs, and oral anti-diabetes drugs. Long-acting insulin derivatives held a<br />
share of 42.7% in the global diabetes devices and drugs market in 2012. Among oral anti-diabetes<br />
drugs, the SGLT-2 inhibitors segment will witness a remarkable CAGR of 76.80% during the<br />
forecast period.<br />
Report overview @ https://www.transparencymarketresearch.com/diabetes-devices-market.html<br />
The global diabetes devices and drugs market is segmented into two segments, namely; diabetes<br />
devices and diabetes drugs class. <strong>Diabetes</strong> devices segment is divided into diabetes diagnostic and<br />
monitoring devices and insulin delivery devices. <strong>Diabetes</strong> diagnostic and monitoring devices class<br />
is further split into analog glucose meters, test strips, lancets and lancing devices, CGM devices and<br />
others. Insulin delivery devices class is divided into insulin pens, insulin syringes, insulin pumps<br />
and insulin injectors. The second segment of the market, that is, drugs class is fragmented into<br />
insulin derivatives, oral anti-diabetes drugs (OADs) and non insulin injectable anti-diabetes drugs.<br />
Insulin derivatives are categorized on the basis of their time of action, such as, rapid-acting, shortacting,<br />
intermediate-acting, long-acting and premixed insulin derivatives. Oral anti-diabetes drugs<br />
are divided into sulphonylureas, biguanides, meglitinides, alpha glucosidase inhibitors,<br />
thiazolidinediones, DPP-IV inhibitors, and SGLT2 inhibitors. GLP-1 agonists represent the<br />
injectable anti-diabetes drugs class. The report also provides in-depth analysis of pipeline diabetes<br />
drugs.<br />
Request A Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?<br />
flag=S&rep_id=14<br />
Summary of Table of Content<br />
1. Introduction<br />
2. Executive Summary<br />
3. Disease Overview: <strong>Diabetes</strong><br />
4. <strong>Market</strong> Overview<br />
5. <strong>Diabetes</strong> <strong>Devices</strong> <strong>Market</strong>, by Device Types<br />
6. Global <strong>Diabetes</strong> Drugs <strong>Market</strong>, by Drug Therapy<br />
7. <strong>Diabetes</strong> <strong>Devices</strong> and Drugs <strong>Market</strong> Revenue, by Geography<br />
8. Competitive Landscape<br />
Get Full Report @ https://www.transparencymarketresearch.com/checkout.php?<br />
rep_id=14<ype=S
About Us<br />
Transparency <strong>Market</strong> Research (TMR) is a global market intelligence company providing business<br />
information reports and services. The company’s exclusive blend of quantitative forecasting and<br />
trend analysis provides forward-looking insight for thousands of decision makers. TMR’s<br />
experienced team of analysts, researchers, and consultants use proprietary data sources and various<br />
tools and techniques to gather and analyze information.<br />
TMR’s data repository is continuously updated and revised by a team of research experts so that it<br />
always reflects the latest trends and information. With extensive research and analysis capabilities,<br />
Transparency <strong>Market</strong> Research employs rigorous primary and secondary research techniques to<br />
develop distinctive data sets and research material for business reports.<br />
Contact<br />
Transparency <strong>Market</strong> Research<br />
State <strong>To</strong>wer,<br />
90 State Street,<br />
Suite 700,<br />
Albany NY - 12207<br />
United States<br />
Tel: +1-518-618-1030<br />
USA - Canada <strong>To</strong>ll Free: 866-552-3453<br />
Sales: sales@transparencymarketresearch.com<br />
Website: www.transparencymarketresearch.com<br />
Blog: http://www.tmrblog.com/
Change language